Breast Implant | Augmentation | US FDA Recommendations

US FDA Recommendations for Patients Who Have or Who Are Considering Breast Implants

• Be aware that breast implants are associated with significant local complications, and the longer the devices remain implanted, the more likely you are to experience a complication. Local complications and adverse outcomes include capsular contracture, reoperation, removal, and implant rupture. Many women also experience breast pain, wrinkling, asymmetry, scarring, and infection.
• Continue to receive routine follow-up with your physician. This includes having periodic MRI exams to detect “silent rupture” of the implant.
• Notify your health care provider if you develop any unusual signs or symptoms including pain, asymmetry, hardness or swelling.
• Recognize that breast implants are not lifetime devices. The longer you have your implants, the more likely it will be for you to have them removed.
• If you have enrolled in an Allergan or Mentor post-approval study, continue to participate. These studies are the best way to collect information about the long-term rates of complications.
• Continue routine screening mammography for breast cancer at intervals recommended by your health care provider based on your age and risk factors.

Source: 

http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/BreastImplants/ucm259866.htm